INFO & BLOG
About diagnosis, treatment and recovery
What is sarcoma and why does it have so many subtypes?
Sarcoma is a rare cancer group arising from connective tissue (muscle, fat, cartilage, vessels, nerve sheath) and bone; the diversity of origin gives it many subtypes.
Why are expert molecular pathology and a translocation panel essential in sarcoma diagnosis?
Given this diversity, the exact subtype needs expert molecular pathology with immunohistochemistry and a translocation panel; incomplete typing affects the treatment plan.
Why is a core (tru-cut) biopsy preferred over open biopsy, and why does the biopsy tract matter?
A planned core biopsy gives accurate subtype diagnosis while the biopsy tract is aligned with surgery, letting later limb-sparing surgery proceed with oncologic safety.
Is limb-sparing surgery possible in every patient?
Our goal is to preserve the limb whenever possible; suitability depends on subtype, size, location and oncologic margin, and is assessed by the board.
Is radiotherapy given before or after surgery, and how is this decided?
Radiotherapy may be neoadjuvant (shrinking before surgery) or adjuvant (strengthening local control after); the board sets the order by subtype, grade and size.
How do the treatments of soft tissue sarcoma and bone sarcoma differ?
In both groups the board decision is central; the order and combination of modalities vary by subtype, grade and location and are planned individually.
In which sarcoma subtypes is targeted therapy considered?
Targeted treatment options are considered in subtypes carrying specific molecular alterations or translocations, based on the molecular pathology profile.
When is microsurgical reconstruction needed and what does it provide?
When tissue loss follows wide excision, microsurgical reconstruction (flap/graft) provides functional repair, supporting limb preservation and function.
Why is the treatment order decided in the council rather than by a single physician?
Because sarcomas are highly diverse, the modality and order are decided in a board where the relevant oncology specialists evaluate together by subtype and grade.
How do the process and follow-up work for international patients?
Once you share imaging and pathology reports, a board review follows; visa, transfer, accommodation, interpreter support and tele-oncology follow-up are provided.